Two Medications, One Pill, Two Different Mechanisms
If you have looked into prescription hair loss treatment in the last year, you have probably seen two recurring patterns. The first is the topical regimen most clinics still default to: oral finasteride plus twice-daily topical minoxidil. The second is the increasingly common oral combination: finasteride and low-dose oral minoxidil delivered in a single daily capsule. Both work. The oral combination is what we offer at Madison Meds through RegrowFuel, and we want to walk through why.
The short version. Finasteride blocks DHT, the hormone primarily responsible for androgenetic alopecia. Minoxidil increases blood flow to follicles and prolongs the growth phase of the hair cycle. They target two completely different mechanisms. Combining them in published trials produces better outcomes than either one alone, which is why combination therapy has been the gold standard in dermatology for years.
What has changed is the delivery. Topical compounded finasteride was once considered a way to reduce systemic side effects. In April 2025 the FDA issued an alert about compounded topical finasteride after a series of adverse event reports showed that systemic absorption through the skin was higher than expected, with side effects similar to the oral product. That alert reshaped how careful providers think about the topical route, and it is one of the reasons Madison Meds is oral only for hair.
How Finasteride Actually Works
Finasteride is a 5-alpha-reductase inhibitor. That is the enzyme that converts testosterone into DHT, the more potent androgen that miniaturizes hair follicles in genetically susceptible men. Lower DHT means less follicle miniaturization, which means slower hair loss and, for many patients, regrowth of follicles that were still alive but no longer producing visible hair.
The standard adult dose is 1 mg daily. At that dose, finasteride is studied in research as reducing scalp DHT by roughly 60 percent. It is FDA-approved for male pattern hair loss, which means there is decades of clinical safety data behind it. Outcomes are individual, and finasteride works on a maintenance basis. If a patient stops taking it, DHT returns to baseline and hair loss resumes within 6 to 12 months.
Finasteride is not for women who are pregnant or who may become pregnant. It is also not appropriate for every man. A licensed-provider evaluation reviews your full history, including mood, sexual function, and any cardiovascular concerns, before any prescription is issued.
How Oral Minoxidil Works and Why the Dose Is So Low
Minoxidil was originally developed as a blood pressure medication. Researchers noticed unexpected hair growth in patients taking it orally, and the topical version was eventually approved over the counter for androgenetic alopecia.
What is interesting is that the hair-growth dose is far lower than the blood pressure dose. Cardiovascular dosing ranges from 10 to 40 mg per day. The dose used for hair loss is typically 1.25 to 5 mg per day, with most modern combination protocols at 2.5 mg. At that level, the cardiovascular effects are minimal in most patients, but the follicle effects are still meaningful. Low-dose oral minoxidil is studied in research as producing density and regrowth outcomes comparable to 5 percent topical minoxidil, with substantially better adherence because patients are not asked to apply liquid to their scalp twice a day.
Common low-dose oral minoxidil considerations include mild increased body hair, occasional ankle swelling, and rare dizziness. A licensed provider should review blood pressure and cardiovascular history before prescribing.
The Combination Effect: Why Two Mechanisms Beat One
Hair loss is not one problem. It is at minimum two problems. There is the hormonal driver, which is DHT, and there is the follicular environment, which is blood flow, oxygenation, and growth-phase duration. Finasteride addresses the first. Minoxidil addresses the second. A drug that does both does not exist. A protocol that combines both is the closest thing.
Published combination data is consistent. A 12-month randomized study of finasteride alone, topical minoxidil alone, and combination therapy reported improvement in 80.5 percent, 59 percent, and 94.1 percent of patients respectively. A more recent retrospective study of an oral combination protocol reported 92.4 percent of patients with stable or improved outcomes over 12 months, with 57.4 percent showing marked improvements. Individual results vary, but the direction is consistent across studies: combination therapy outperforms monotherapy.
Why Oral-Only for Hair at Madison Meds
This is the part most comparison pages do not address. There are three plausible delivery strategies for finasteride and minoxidil. Each has trade-offs.
| Approach | Pros | Cons |
|---|---|---|
| Oral finasteride + topical minoxidil | Decades of evidence; topical minoxidil is over the counter | Twice-daily topical application; adherence drops sharply after month 3; scalp irritation |
| Topical compounded finasteride + minoxidil | Marketed as lower systemic exposure | FDA issued a 2025 alert noting systemic absorption and adverse events similar to oral finasteride; not FDA-approved |
| Oral finasteride + oral minoxidil (combination capsule) | Once-daily pill; better adherence; decades of safety data on both molecules; simpler protocol | Requires cardiovascular review for oral minoxidil; not appropriate for every patient |
The oral combination is what we settled on for RegrowFuel because it preserves the efficacy advantages of combination therapy while eliminating the adherence problem of topicals and the absorption uncertainty of compounded topical finasteride. Through Madison Meds, an oral finasteride and minoxidil regimen may be considered for eligible patients after a licensed-provider evaluation, with the medication dispensed by a US-licensed compounding pharmacy.
What to Expect on Timeline
Hair grows slowly. That is the hardest thing about any hair loss treatment because the timeline does not match the urgency most patients feel.
- Weeks 1 to 4: No visible change. Some patients notice mild shedding around weeks 2 to 6 as dormant follicles cycle out before new growth begins. This is normal and short-lived.
- Months 2 to 3: Shedding typically stabilizes. Most patients see reduced rate of loss before they see new growth.
- Months 4 to 6: Visible density improvement at the crown and around the hairline. Texture often improves before count does.
- Months 9 to 12: Peak effect. Density, count, and texture are usually stable by this point.
- Beyond 12 months: Maintenance phase. The therapy is ongoing. Stopping returns DHT and follicle activity to baseline within 6 to 12 months.
Photos at month 0, month 3, month 6, and month 12 are the best way to track progress. Day to day, hair changes are invisible. Across three months, they are obvious.
Who Is and Is Not a Candidate
Combination oral therapy is most appropriate for adult men with androgenetic alopecia, family history of male pattern baldness, early to moderate thinning at the crown or hairline, or limited results from topical-only treatments. It may be considered for eligible patients after a licensed-provider evaluation.
It is generally not appropriate for women who are pregnant or who may become pregnant, patients with certain cardiovascular conditions, patients on interacting medications, or patients with non-androgenetic forms of hair loss such as alopecia areata, telogen effluvium, or scarring alopecia. A licensed provider in the Madison Meds network reviews medical history, current medications, and goals before any prescription decision.
How RegrowFuel Fits In
RegrowFuel is the Madison Meds oral hair loss program. It is family-owned, oral only, and delivered through telehealth. The intake covers your hair loss pattern, age of onset, family history, current medications, and any cardiovascular or reproductive considerations. A licensed provider in our independent network reviews your case and, if appropriate, prescribes the oral combination. The medication is dispensed by a US-licensed compounding pharmacy and shipped to you in a discreet package. Follow-up check-ins are scheduled so the protocol can be adjusted based on response and tolerability.
Pricing is bundled. There is no separate consult fee, no per-refill markup, and no upsell to add a topical layer we do not believe in. If you want a broader overview of how the different hair loss treatments compare, our treating hair loss guide covers the full landscape.
Frequently Asked Questions
Is oral minoxidil better than topical minoxidil for hair loss?
Low-dose oral minoxidil is studied in research as producing similar density and regrowth outcomes to topical 5 percent minoxidil, with better adherence because it removes the twice-daily application step. Topical works too. Oral is often easier to stick with. Outcomes are individual.
Why does Madison Meds use oral finasteride and minoxidil instead of topical?
The FDA issued an alert in 2025 about compounded topical finasteride absorption and adverse events. Oral formulations have decades of safety data behind them, simpler dosing, and one bottle to manage. Through Madison Meds, an oral combination of finasteride and minoxidil may be considered for eligible patients after a licensed-provider evaluation, with the medication dispensed by a US-licensed compounding pharmacy.
How long does it take to see results from oral finasteride and minoxidil?
Most patients notice reduced shedding within 8 to 12 weeks and visible density improvements at 4 to 6 months. Full results take 9 to 12 months because the hair cycle is slow. Educational content. Not medical advice. Individual results vary.
What are the side effects of oral finasteride and minoxidil?
Common finasteride side effects include changes in libido or mood, usually mild and reversible. Common low-dose oral minoxidil side effects include increased body hair, mild swelling, and occasional dizziness. A licensed-provider evaluation reviews your cardiovascular and reproductive history before any prescription.
Can women take oral finasteride for hair loss?
Finasteride is not recommended for women who are pregnant or may become pregnant. Some providers do prescribe low-dose oral minoxidil alone for women with androgenetic alopecia. A licensed provider must review your specific situation and any reproductive considerations.
Educational content. Not medical advice. Compounded medications are not FDA-approved drugs. A licensed provider in the Madison Meds network reviews your medical history before any prescription, and not all patients are appropriate candidates for combination hair loss therapy. Individual results vary. Consult licensed providers about treatment decisions.
See if RegrowFuel is right for your hair
A licensed provider in the Madison Meds network will review your hair loss pattern, history, and goals and determine whether the oral combination is appropriate. RegrowFuel may be considered for eligible patients after a licensed-provider evaluation, with the medication dispensed by a US-licensed compounding pharmacy.
View RegrowFuel